Analysis of clinical data from BLCA patients in the TCGA database and HBlaU079Su01 cohort revealed a positive association between poor prognosis and high ACAT1 expression, consistent with findings in prostate and uterine cancers 23, 26, 27. The gene discussed is ACAT1; the disease is bladder transitional cell carcinoma.